Associated Papers
MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations.
Georgitsi M
Best Practice & Research. Clinical Endocrinology & Metabolism, 2010
Select a paper to view details